Clover Health Investments CLOV Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Clover Health Investments in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Clover Health Investments’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Clover Health Investments's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Clover Health Investments's cash & equivalents?
- Clover Health Investments (CLOV) reported cash & equivalents of $173.27M in Q1 2026.
- How has Clover Health Investments's cash & equivalents changed year-over-year?
- Clover Health Investments's cash & equivalents increased by 11.5% year-over-year, from $155.44M to $173.27M.
- What is the long-term trend for Clover Health Investments's cash & equivalents?
- Over 5 years (2020 to 2025), Clover Health Investments's cash & equivalents has grown at a -3.2% compound annual growth rate (CAGR), from $92.35M to $78.3M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.